Aehr Test Systems Rallies 13% as Hedge Funds Pile In Eightfold Ahead of Lake Street Conference

Aehr Test Systems, Inc. (NASDAQ: AEHR) climbed 13.1% Friday as investors positioned ahead of the company’s institutional investor meetings this week — and newly disclosed 13F data revealed just how aggressively professional money moved into the small-cap semiconductor test name during the second quarter. Hedge fund positions in AEHR surged 678%, jumping from $60.9 million to $473.97 million, while the number of funds holding the stock rose from 25 to 34.

Key Points

• AEHR gained 13.1% Friday, ahead of institutional investor presentations scheduled for this week.
• Hedge fund holdings exploded 678% quarter-over-quarter, climbing from $60.9 million to $473.97 million as fund count rose from 25 to 34.
• CEO Gayn Erickson and CFO Chris Siu present Thursday, September 10 at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference in New York.
• Fiscal 2027 guidance calls for $130–$150 million in revenue — 160% to 200% year-over-year growth — with non-GAAP net income margins of 18% to 22%.
• Effective backlog reached $100.6 million following record fiscal Q4 bookings of $60.7 million.
• A $22 million follow-on order from Aehr’s lead AI processor customer landed in August for FOX-XP wafer-level burn-in systems.
• Cash climbed to $116.5 million at fiscal year end, up from $37.1 million in late February.

What Drove Friday’s Move

Two forces converged. First, Aehr (NASDAQ: AEHR) confirmed that CEO Gayn Erickson and CFO Chris Siu will meet institutional investors at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference, held Thursday, September 10 at the Metropolitan Club in New York City. Traders routinely front-run these appearances in small-cap names, particularly when a company has recent order momentum to discuss.

Second, the broader semiconductor complex rallied. SanDisk, Cerebras Systems, Astera Labs and SK Hynix all advanced alongside Aehr on Friday, so part of the move reflected sector beta rather than company-specific news.

Still, the hedge fund data reframes the story. A 678% increase in combined institutional positions over a single quarter does not happen on sector drift — it happens when professional investors conclude that a business inflection is underway.

The Business Behind the Positioning

Aehr Test Systems builds test and burn-in equipment that screens semiconductors for defects before they reach production. Erickson describes the company’s role directly: “Aehr delivers complete turnkey solutions that improve the quality, reliability, and yield of semiconductors.”

That equipment now serves four demand streams — AI processors, silicon carbide devices, gallium nitride components and silicon photonics. Critically, the first of those has become the growth engine. “We are seeing strong traction with AI processors in both wafer-level and package-level formats,” Erickson said.

The economics explain the enthusiasm. As AI accelerators grow larger and more expensive, discovering a defective die after packaging costs chipmakers far more than catching it at the wafer stage. Consequently, wafer-level burn-in has shifted from a nice-to-have into a production requirement for high-value AI silicon — and Aehr sells directly into that need.

Order Flow Backs the Thesis

In August, Aehr announced a $22 million follow-on order from its lead wafer-level AI processor customer, described as a leading provider of advanced AI training and inference processors. The order covers multiple fully automated FOX-XP wafer-level burn-in systems, FOX WaferPak full-wafer Contactors and integrated FOX WaferPak Auto Aligners, with each system testing and burning in nine 300mm wafers simultaneously. Shipments run over roughly six months for installation at the customer’s high-volume manufacturing partner in Taiwan.

Erickson framed the significance plainly: “This $22 million follow-on order represents another significant expansion of WLBI capacity by our lead AI processor customer and further validates the use of our FOX-XP platform in high-volume production.”

Meanwhile, silicon carbide has quietly re-accelerated. Erickson reported roughly $8 million in new silicon carbide orders in a single month as electric vehicle programs expand globally — a segment many investors had written off during the EV slowdown.

The Numbers That Set Up Fiscal 2027

Aehr’s fiscal 2026 closed May 29, 2026, and the results tell a two-speed story.

Fiscal Q4 delivered the inflection. Revenue reached $18.8 million, up from $14.1 million a year earlier. GAAP net income came in at $1.4 million, or $0.04 per share, with non-GAAP net income of $3.6 million, or $0.11 per share. Bookings hit a record $60.7 million, lifting backlog to $80.6 million — and to $100.6 million on an effective basis once post-quarter bookings are included. Cash strengthened dramatically as well, rising to $116.5 million from $37.1 million on February 27, 2026.

The full year, however, went backward. Revenue fell to $50.0 million from $59.0 million in fiscal 2025, producing a GAAP net loss of $7.1 million, or $(0.23) per share, against non-GAAP net income of $0.9 million. Operations consumed $3.3 million in cash.

That contrast matters. Investors buying AEHR today are underwriting the fourth quarter and the backlog, not the trailing twelve months.

Management’s guidance makes the bet explicit: fiscal 2027 revenue of $130 million to $150 million, representing 160% to 200% growth, with non-GAAP net income margins of 18% to 22%. Erickson pointed to “AI production customers… significantly ramping capacity” and noted the completion of successful benchmark testing with a major AI accelerator supplier.

What to Watch Next

Thursday’s Lake Street appearance offers the near-term catalyst. Investors should listen for any color on additional AI processor customers beyond the lead account, on silicon carbide order durability, and on whether management reaffirms or refines the fiscal 2027 range.

Beyond that, concentration deserves attention. A meaningful share of the AI-driven backlog traces to one lead customer, so follow-on order cadence from that account — and evidence of a second high-volume AI customer — will determine whether the guided ramp holds.

Position sizing applies here as it does with any small-cap equipment supplier levered to a capital spending cycle. Guidance implying triple-digit growth leaves little room for slippage, and a single pushed shipment can move a quarter materially in a business this size.